Pathogenesis and treatment of mitochondrial myopathies: Recent advances

Acta Myologica

Volumn 29, Issue OCTOBER, 2010, Pages 333-338

  DiMauro, S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Homoplasmy; Mendelian mitochondrial disorders; MtDNA related disorders; Pathogenesis; Therapy

Indexed keywords

BEZAFIBRATE; MITOCHONDRIAL DNA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL NUCLEUS TRANSPLANTATION; HUMAN; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MYOPATHY; MNGIE SYNDROME; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRONUCLEUS; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BEZAFIBRATE; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MITOCHONDRIAL MYOPATHIES; MUTATION; NUCLEAR TRANSFER TECHNIQUES;

EID: 78651420640     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Boyer PD. A research journey with ATP synthase. J Biol Chem 2002; 277: 39045-61.
2. Stock D, Gibbons C, Arechaga I, et al. The rotary mechanism of ATP synthase. Curr Opin Struct Biol 2000; 10: 672-9.
3. Efremov RG, Baradaran R, Sazanov LA. The architecture of respiratory complex I. Nature 2010; 465: 441-5.
4. Ohnishi T. Piston drives a proton pump. Nature 2010; 465: 428-9.
5. Holt IJ, Harding AE, Petty RK, et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
6. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T > G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992; 50: 852-8.
7. DiMauro S, Davidzon, G. Mitochondrial DNA and disease. Ann Med 2005; 37: 222-32.
8. Tanji K, Kunimatsu T, Vu TH, et al. Neuropathological features of mitochondrial disorders. Cell Develop Biol 2001; 12: 429-39.
9. Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual meurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006; 32: 359-73.
10. Sparaco M, Schon EA, DiMauro S, et al. Myoclonic epilepsy with ragged-red fibers (MERRF): an immunohistochemical study of the brain. Brain Pathol 1995; 5: 125-33.
11. Tanji K, Schon EA, DiMauro S, et al. Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium. J Neurol Sci 2000; 178; 29-36.
12. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-30.
13. Carelli V, Barboni P, Sadun AA. Mitochondrial ophthalmology. In: DiMauro S, Hirano M, Schon EA, eds. Mitochondrial Medicine. London: Informa Healthcare 2006, pp. 105-142.
14. Li X, Zhang LS, Fischel-Ghodsian N, et al. Biochemical characterization of the deafness-associated mitochondrial tRNASer(UCN) A7445G mutation in osteosarcoma cell cybrids. Biochem Biophys Res Comm 2005; 328: 491-8.
15. Santorelli FM, Tanji K, Manta P, et al. Maternally inherited cardiomyopathy: an atypical presentation of the 12S rRNA A1555G mutation. Am J Hum Genet 1999; 64: 295-300.
16. Taylor RW, Giordano C, Davidson MM, et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited cardiomyopathy. J Am Coll Cardiol 2003; 41: 1786-96.
17. DiMauro S, Nicholson JF, Hays AP, et al. Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol 1983; 14: 226-34. (Pubitemid 13030277)
18. Horvaui R, Kemp JP, Tuppen HA, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 2009; 132: 3165-74.
19. Gomez-Duran A, Pacheu-Grau D, López-Gallardo E, et al. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 2010; 19: 3343-53.
20. Wallace DC. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005; 354: 169-80.
21. DiMauro S. A history of mitochondrial diseases. J Inner Metab Dis 2010, DOI10.1007/S10545-010-9082-X.
22. Tiranti V, D'Adamo P, Briem E, et al. Ethylmalonic encephalopathy is caused by mutations in ETHEl, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 2004; 74: 239-52.
23. Tiranti V, Briem E, Lamantea E, et al. ETHEl mutations are specific to ethylmalonic encephalopathy. J Med Genet 2006; 43: 340-6.
24. Tiranti V, Viscomi C, Hildebrandt T, et al. Loss of ETHEl, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nature Med 2009; 15: 200-5.
25. Di Fonzo A, Ronchi D, Lodi T, et al. The mitochondrial disulfide relay system protein GFERis mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet 2009; 84: 594-604.
26. Massa V, Fernandez-Vizarra E, Alshahwan S, et al. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 2008; 82: 1281-9.
27. Miller C, Saada A, Shaul N, et al. Defective mitochondrial translation caused by a ribosomal protein (MRPS 16) mutation. Ann Neurol 2004; 56: 734-8.
28. Antonicka H, Sasarman F, Kennaway NG, et al. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol. Genet 2006; 15: 1835-46.
29. Coenen MJH, Antonicka H, Ugalde C, et al. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 2004; 351: 2080-6.
30. Smeitink JAM, Elpeleg O, Antonicka H, et al. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 2006; 79: 869-77.
31. Valente L, Tiranti V, Marsano RM, et al. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EGFl and EFTu. Am J Hum Genet 2007; 80: 44-58.
32. Bykhovskaya Y, Casas KA, Mengesha E, et al. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004; 74: 1303-8. (Pubitemid 38669331)
33. Scheper GC, an der Klok T, van Andel RJ, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nature Genet 2007; 39: 534-8.
34. Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 2007; 81: 857-62.
35. Smits P, Smeitink JAM, van den Heuvel B. Mitochondrial translation and beyond; Processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010, doi:1155/2010/737385.
36. Hirano M, Nishigaki Y, Marti R. Mitochondrial Neurogastrintestinal Encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 2004; 10: 8-17.
37. Nishino I, Spinazzola A, Hirano M. Thymidine Phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-92.
38. Valentino ML, Marti R, Tadesse S, et al. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrintestinal encephalomyopathy (MNGIE). FEBS Lett 2007; 581: 3410-4.
39. Lopez LC, Akman HO, Garcfa-Cazorla A, et al. Umbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol. Genet 2009; 18: 714-22.
40. Spinazzola A, Marti R, Nishino I, et al. Altered thymidine metabolism due to defects of thymidine Phosphorylase. J Biol Chem 2002; 277: 4128-32.
41. la Marca G, Malvagia S, Casetta B, et al. Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS. J Mass Spectrom 2006; 41: 586-92.
42. Yavuz H, Ozel A, Christensen M, et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007; 64: 435-8. (Pubitemid 46425702)
43. Hirano M, Martí R, Casali C, et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006; 67: 1458-60.
44. Schon EA, DiMauro S, Hirano M, et al. Therapeutic prospects for mitochondrial disease. Trends Mol. Med 2010; 16: 268-76.
45. Schupbach M, Benoist J-F, Casali C, et al. Allogeneic hematopoietic stem cell transplantation (HSCT) for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neurology 2009, 73: 332.
46. Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1alpha drives the formation of slow-twitch muscle fibers. Nature 2002; 418: 797-801.
47. Rohas LM, St-Pierre J, Uldry M, et al. A fundamental system of cellular energy homeostasis regulated by PGC-1 alpha. Proc Natl Acad Sci USA 2007; 104: 7933-8.
48. Djouadi F, Bastin J. PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. J Inher Metab Dis 2008; 31: 217-25.
49. Gobin-Limballe S, Djouadi F, Aubey F, et al. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase by bezafibrate in patients fibroblasts: towards a genotype-based therapy. Am J Hum Genet 2007; 81: 1133-43.
50. Bastin J, Aubey F, Rotig A, et al. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J Clin Endocrinol Metab 2008; 93: 1433-41. (Pubitemid 351519745)
51. Wenz T, Diaz F, Spiegelman BM, et al. C.T. Activation of the PPAR/PGC-1 alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 2008; 8: 249-55.
52. Wenz T. PGC-1 alpha activation asa therapeutic approach in mitochondrial disease. IUBMB Life 2009; 61: 1051-62.
53. Craven L, Tuppen HA, Greggains GD, et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010; 465: 82-5.
54. Tachibana M, Sparman M, Sritanaudomchai H, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009; 461: 367-72.
55. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656-68.